GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AB Science (FRA:A8D) » Definitions » Total Equity

AB Science (FRA:A8D) Total Equity : €-24.60 Mil (As of Jun. 2024)


View and export this data going back to 2011. Start your Free Trial

What is AB Science Total Equity?

AB Science's total equity for the quarter that ended in Jun. 2024 was €-24.60 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

AB Science Total Equity Historical Data

The historical data trend for AB Science's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AB Science Total Equity Chart

AB Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.83 -19.55 -23.20 -35.67 -21.01

AB Science Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -29.53 -35.67 -19.23 -21.01 -24.60

AB Science Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

AB Science's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=25.499-46.509
=-21.01

AB Science's Total Equity for the quarter that ended in Jun. 2024 is calculated as

Total Equity=Total Assets(Q: Jun. 2024 )-Total Liabilities(Q: Jun. 2024 )
=22.982-47.581
=-24.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AB Science Total Equity Related Terms

Thank you for viewing the detailed overview of AB Science's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

AB Science Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AB Science (FRA:A8D) » Definitions » Total Equity
Comparable Companies
XPAR:MLCOT XPAR:ALRPD XPAR:EAPI ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB BOM:500124 VTRS NBIX SZSE:000963 SHSE:600085 XPAR:IPN
Traded in Other Exchanges
ABSCF:USA 0Q77:UK AB:France
Address
3, Avenue George V, Paris, FRA, 75008
Website
https://www.ab-science.com
AB Science is a France-based pharmaceutical company specialized in the research, discovery, development, and marketing of protein kinase inhibitors. It is engaged in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical factor in the field of cancer, chronic inflammatory diseases, neurological degenerative disorders and central nervous systems diseases in both human and veterinary medicine.

AB Science Headlines

No Headlines